Subtopic Deep Dive

Calcineurin-NFAT Signaling in Cardiac Hypertrophy
Research Guide

What is Calcineurin-NFAT Signaling in Cardiac Hypertrophy?

Calcineurin-NFAT signaling in cardiac hypertrophy is a calcium-dependent pathway where calcineurin dephosphorylates NFAT transcription factors, enabling their nuclear translocation and pathological gene expression in cardiomyocytes under pressure overload.

Calcineurin activates NFAT in response to sustained calcium signals from pressure overload, driving hypertrophic growth distinct from physiological hypertrophy (Wilkins et al., 2003, 756 citations). This pathway reprograms cardiac genes, leading to fibrosis and heart failure. Over 10 key papers since 1998 detail its mechanisms, with Hogan et al. (2003, 1948 citations) providing foundational NFAT regulation insights.

Curated Papers

Key Challenges

Why It Matters

Calcineurin-NFAT inhibition prevents pathological hypertrophy in mouse models, offering therapeutic targets for heart failure (Wilkins et al., 2003). PDE5A inhibition reverses hypertrophy via cGMP pathways intersecting calcineurin signaling (Takimoto et al., 2005, 894 citations). TRPC6 channels sustain calcineurin activation in remodeling, linking ion flux to disease progression (Kuwahara et al., 2006, 546 citations). These findings guide drug development like calcineurin inhibitors in clinical trials for hypertrophic cardiomyopathy.

Key Research Challenges

Distinguishing Pathological vs Physiological Hypertrophy

Calcineurin-NFAT drives pathological but not physiological growth, complicating selective targeting (Wilkins et al., 2003). Mouse models show NFAT translocation only under pressure overload. Therapeutic inhibition risks immunosuppression from broad calcineurin blockade.

Calcium Signal Specificity in Cardiomyocytes

Perinuclear InsP3-dependent Ca2+ activates local calcineurin-NFAT without global calcium rises (Wu, 2006, 481 citations). TRPC6 sustains pathologic Ca2+ entry (Kuwahara et al., 2006). Spatial Ca2+ dynamics challenge pathway isolation.

Fibroblast Contributions to Hypertrophy

Myofibroblast activation via lineage tracing reveals fibrosis drivers intersecting NFAT signaling (Kanisicak et al., 2016, 871 citations). Cardiac fibroblast conversion amplifies hypertrophy. Integrating stromal and cardiomyocyte signals remains unresolved.

Essential Papers

Transcriptional regulation by calcium, calcineurin, and NFAT

Patrick G. Hogan, Lin Chen, Julie Nardone et al. · 2003 · Genes & Development · 1.9K citations

The NFAT family of transcription factors encompasses five proteins evolutionarily related to the Rel/NF B family (Chytil and Verdine 1996; Graef et al. 2001b). The primordial family member is NFAT5...

A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type

Eva R. Chin, Eric N. Olson, James A. Richardson et al. · 1998 · Genes & Development · 997 citations

Slow- and fast-twitch myofibers of adult skeletal muscles express unique sets of muscle-specific genes, and these distinctive programs of gene expression are controlled by variations in motor neuro...

Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy

Eiki Takimoto, Hunter C. Champion, Manxiang Li et al. · 2005 · Nature Medicine · 894 citations

Genetic lineage tracing defines myofibroblast origin and function in the injured heart

Onur Kanisicak, Hadi Khalil, Malina J. Ivey et al. · 2016 · Nature Communications · 871 citations

Abstract Cardiac fibroblasts convert to myofibroblasts with injury to mediate healing after acute myocardial infarction (MI) and to mediate long-standing fibrosis with chronic disease. Myofibroblas...

Calcineurin/NFAT Coupling Participates in Pathological, but not Physiological, Cardiac Hypertrophy

Benjamin J. Wilkins, Yan‐Shan Dai, Orlando F. Bueno et al. · 2003 · Circulation Research · 756 citations

Calcineurin (PP2B) is a calcium/calmodulin-activated, serine-threonine phosphatase that transmits signals to the nucleus through the dephosphorylation and translocation of nuclear factor of activat...

The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy

Ahmet Uçar, Shashi Kumar Gupta, Jan Fiedler et al. · 2012 · Nature Communications · 600 citations

TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling

Koichiro Kuwahara, Yanggan Wang, John McAnally et al. · 2006 · Journal of Clinical Investigation · 546 citations

The heart responds to injury and chronic pressure overload by pathologic growth and remodeling, which frequently result in heart failure and sudden death. Calcium-dependent signaling pathways promo...

Reading Guide

Foundational Papers

Start with Hogan et al. (2003, 1948 citations) for NFAT basics, then Wilkins et al. (2003, 756 citations) for cardiac specificity, and Chin et al. (1998, 997 citations) for calcineurin transcriptional control.

Recent Advances

Kanisicak et al. (2016, 871 citations) on myofibroblast roles; Uçar et al. (2012, 600 citations) on miRNA regulation.

Core Methods

Pressure overload mouse models (Wilkins 2003); Ca2+ imaging and InsP3R studies (Wu 2006); lineage tracing for fibroblasts (Kanisicak 2016); genetic knockout of CnAβ (Chin 1998).

How PapersFlow Helps You Research Calcineurin-NFAT Signaling in Cardiac Hypertrophy

Discover & Search

Research Agent uses citationGraph on Wilkins et al. (2003) to map 756-citation network linking to Hogan et al. (2003, 1948 citations) for NFAT basics and Kuwahara et al. (2006) for TRPC6 integration. exaSearch queries 'calcineurin NFAT cardiac hypertrophy pressure overload' retrieves 250M+ OpenAlex papers filtered by citations. findSimilarPapers expands to miRNA regulators like Uçar et al. (2012).

Analyze & Verify

Analysis Agent runs readPaperContent on Wilkins et al. (2003) to extract NFAT dephosphorylation data, then verifyResponse with CoVe checks claims against Takimoto et al. (2005). runPythonAnalysis processes Ca2+ signaling datasets from Wu (2006) with NumPy for peak detection. GRADE grading scores evidence strength for pathological specificity (A-grade for mouse models).

Synthesize & Write

Synthesis Agent detects gaps in TRPC6-NFAT coupling post-Kuwahara (2006) via contradiction flagging with recent papers. Writing Agent uses latexEditText to draft hypertrophy pathway reviews, latexSyncCitations for 10+ refs, and latexCompile for publication-ready PDFs. exportMermaid generates signaling diagrams from Chin et al. (1998) to Olson pathways.

Use Cases

"Analyze Ca2+ signal datasets from TRPC6 papers for NFAT activation thresholds"

Research Agent → searchPapers 'TRPC6 calcineurin NFAT' → Analysis Agent → runPythonAnalysis (pandas/matplotlib on extracted data from Kuwahara 2006) → threshold plots and statistical p-values output.

"Write LaTeX review on calcineurin inhibitors in hypertrophy models"

Synthesis Agent → gap detection on Wilkins 2003/Takimoto 2005 → Writing Agent → latexEditText (intro/methods) → latexSyncCitations (10 papers) → latexCompile → camera-ready PDF with figure captions.

"Find GitHub code for NFAT nuclear translocation simulations"

Research Agent → paperExtractUrls (Wu 2006) → Code Discovery → paperFindGithubRepo → githubRepoInspect → runnable Python sims for InsP3-Ca2+ models output.

Automated Workflows

Deep Research workflow scans 50+ papers via searchPapers on 'calcineurin NFAT hypertrophy', chains citationGraph to Wilkins (2003), and outputs structured review with GRADE scores. DeepScan applies 7-step CoVe to verify TRPC6 claims from Kuwahara (2006) against Hogan (2003). Theorizer generates hypotheses on miRNA-212/132 modulation of NFAT from Uçar (2012) + Chin (1998).

Try Doxa for Calcineurin-NFAT Signaling in Cardiac Hypertrophy Research

Frequently Asked Questions

What defines Calcineurin-NFAT signaling in cardiac hypertrophy?

Calcineurin dephosphorylates NFAT upon sustained Ca2+ from pressure overload, enabling nuclear translocation and pathological gene expression (Wilkins et al., 2003; Hogan et al., 2003).

What are key methods to study this pathway?

Mouse models with pressure overload induce NFAT translocation; genetic tracing tracks myofibroblasts (Kanisicak et al., 2016); Ca2+ imaging reveals perinuclear signals (Wu, 2006).

What are the most cited papers?

Hogan et al. (2003, 1948 citations) on NFAT regulation; Wilkins et al. (2003, 756 citations) on pathological hypertrophy; Takimoto et al. (2005, 894 citations) on PDE5A reversal.

What open problems exist?

Selective NFAT inhibition without immunosuppression; fibroblast-cardiomyocyte crosstalk (Kanisicak et al., 2016); TRPC6-specific blockers for Ca2+ entry (Kuwahara et al., 2006).